Trial intelligence / Profile preview

HEMODEX: Detralex versus placebo in acute hemorrhoidal attack

2004-002707-32Phase 4Completed

Sponsor
Servier
Start
Nov 2004
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in hemorrhoid comparing Detralex with Placebo (2 arms). Primary endpoint: Global efficacy of Detralex vs placebo. Started Nov 2004; status: completed.

02

Drugs

diosmin
03

Conditions

hemorrhoid

Beyond the preview

Go deeper on 2004-002707-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-002707-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call